Osimert 80 MG (Osimertinib) – 30 Tablets

Generic equivalent of Osimertinib® · Manufactured by Everest Pharmaceuticals Limited
(1 customer review)

$80.00
Prices subject to change

Osimert 80 mg  (Osimertinib)  is a inhibitor indicate for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC), as detected by an FDA-approved test, who progress on or after EGFR TKI therapy.

whatsapp_qr
Whatsapp +8801922101029